ILLUSIO is a plastic surgery simulation tool that enables a surgeon and patient to have a visual discussion about all of the possible outcomes of breast augmentation. Our revolutionary artistic platform gives the surgeon the perfect opportunity to create the ideal size and shape for every possible situation. The best part is that now the surgeon and patient will share the same visual expectation of surgery, and equally important, have a mutual understanding of the limitations of surgery based on the patients unique anatomy. Remember, ILLUSIO is primarily an artistic tool created to manage patient expectations. With ILLUSIO, the overall time per consult could become shorter and patients could make decisions quicker and with much more confidence. Above all, they will have fun with the process. The ability to look into our Virtual Mirror and see themselves with their virtual breasts is new and exciting and provides a real Wow experience. As patients become engaged in the process they will very likely want to share their ILLUSIO experience with their friends and family. Source
No articles found.
Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and ...
Founded in 1996 as a spinoff from the Harvard-M...
Aytu is committed to better health for men and women here at home and worldwide. W...
Aytu is committed to better health for men and ...
AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage co...
AVROBIO, Inc., a leader in lentiviral-based gen...
Robovet Corporation has developed a new MR imaging technology that can also help t...
Robovet Corporation has developed a new MR imag...
Jasperate, Inc. is a startup company in the truest sense. We have a strong managem...
Jasperate, Inc. is a startup company in the tru...
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...
Sangamo Therapeutics, Inc. is focused on transl...
Digital Social Retail has developed proprietary software that allows customers to ...
Digital Social Retail has developed proprietary...
Join the National Investor Network and get the latest information with your interests in mind.